ÄÌÌÇÖ±²¥

DEGREE REQUIREMENTS

All students pursuing a master’s degree in Biochemical Engineering are required to take the following for a total of 30 credits with a minimum GPA of 3.0

  • Two (2) core courses in Biochemical Engineering (3 credits per course, 6 credits total)
  • Minimum of three (3) additional courses in Biochemical Engineering (3 credits per course, 9 credits total)
  • Maximum two (2) courses in Bioengineering (3 credits per course)
  • PLUS, the following based on whether the student is pursuing a thesis:

Thesis Option

  • Maximum three (3) bio-science courses (3 credits per course)
  • Maximum three (3) courses in Chemical Engineering (3 credits per course)
  • M.S. Thesis (6 credits)

Total Credits: 6 (core) + 9 (Biochemical Engineering) + 9 (Bio-science, Bioengineering and/or Chemical Engineering) + 6 (thesis) = 30

Non-Thesis Option

  • Maximum two (2) courses in Bioengineering (3 credits per course)
  • Maximum four (4) bio-science courses (3 credits per course)
  • Maximum four (4) courses in chemical engineering (3 credits per course)

Total Credits: 6 (core) + 9 (Biochemical Engineering) + 15 (Bio-science, Bioengineering and/or Chemical Engineering) = 30

Available courses for a master’s degree in Biochemical Engineering are listed below. Students may take courses not listed below, but they should get approved by the program director.

Required Courses (offered annually)

  • CHE 8588 - Biochemical Engineering I
  • CHE 8589 - Biochemical Engineering II

Elective Courses (biochemical)

  • CHE 7005 - Global Pharmaceutical Business
  • CHE 7587 - Biopharm Facility Design
  • CHE 7651 - Survey of Biomass Conversion
  • CHE 8586 - Biomaterials & Drug Delivery
  • CHE 8591 - Gene & Cell Therapy
  • CHE 8592 - Protein Engineering
  • CHE 8663 - Systems Biology

Elective Courses (biochemical and chemical)

  • CHE 7002 - Quantitative Safety Tech
  • CHE 7570 - Polymer Science & Engineering
  • CHE 7580 - CHE Economics
  • CHE 8550 - Chem Eng Reactors
  • CHE 8551 - Chem Kinetics and Catalysis
  • CHE 8558 - Process Design I
  • CHE 8563 - Transport Phenomena
  • CHE 8565 - Heat Transfer
  • CHE 8572 - Separation Processes II
  • CHE 8575 - Thermodynamics
  • CHE 8579 - Adv Process Modeling/Analysis
  • ME 8010 - Special Topics in ME

Bioscience Courses

  • Graduate courses that are provided by Department of Biology and approved by the program director

Thesis

  • CHE 9024 - CHE Thesis I
  • CHE 9025 - CHE Thesis II

Dr. Zuyi (Jacky) Huang
Biochemical Engineering Graduate Studies

STUDENT PERSPECTIVES

Evan Kurt, graduate of ÄÌÌÇÖ±²¥'s Master's in Biochemical Engineering program.

"As a full-time student, I enjoyed the independence I had on my research project, but also appreciated the support of Dr. Bill Kelly who provided guidance and connected me with people in industry for further discussion on the topic.â€

Evan Kurt, PhD student and graduate researcher, Biomedical Engineering, Duke University

 

Emily Harris, Master’s in Biochemical Engineering.

“I'm grateful to have been part of a graduate program that was small enough to allow me to interact with all of the other graduate students and all of the faculty. It helped me develop a really well-rounded approach to my research.â€

Emily Harris ’20 MSBChE, Associate CAR T Cell Scientist, Janssen Pharmaceuticals

 

“There were a lot of pharmaceutical courses throughout the program that were in line with what I do every day. The combination of theory and the practical application in the classroom helped me to apply what I learned to what I do in the lab at work.â€

Mike Weiss ’09 ChE, ’16 MSBChE, Senior Supply Execution Manager, Janssen Pharmaceuticals.

WHERE ARE THEY NOW?

Luke Badalaty ’12 ChE, ’15 MSBChE

Luke Badalaty ’12 ChE, ’15 MSBChE

Title: Associate Director, Project Management

Company: Kyverna Therapeutics

Colleen Clark, Master’s in Biochemical Engineering.

Colleen Clark, PhD, ’12 ChE, ’14 MSBChE

Title: Manager, Strategic Options and Assessment

Company: Bristol-Myers Squibb

Matthew Tucker ’17 MSBChE

Matthew Tucker ’17 MSBChE

Title: Vaccine Process Development

Company: Takeda